No Delays: How Medable Achieves A 99% Device Shipment Rate

Medable, a leading provider of solutions for clinical trials, has achieved an impressive 99% device shipment rate, ensuring that sites and participants are prepared for trials. This success is due to the expertise and hard work of Medable's team, who follow a proven model that includes building partnerships, developing customs expertise, and proactively managing supply chain and technology changes.

The team consists of experts in device technology, supply chain operations, international distribution, and supply chain coordination. They work closely with vendors in key regions to minimize delays and ensure proximity to clients. By anticipating device needs based on data and industry trends, Medable stays ahead of device obsolescence and manages customs delays effectively.

The Mobile Device Management team at Medable is particularly skilled at researching next-generation devices and predicting device obsolescence. They collaborate with multiple couriers and suppliers to guarantee redundancy and avoid disruptions in the supply chain.

Medable's exceptional device delivery performance has led to requests for support from customers in trials they are not currently contracted for. This success is a testament to the company's commitment to excellence and its ability to deliver high-quality data collection during clinical trials. In addition to device shipment, the company offers a range of solutions for the pharmaceutical industry, focusing on oncology and vaccines. They serve mid to large pharmaceutical companies, emerging biopharma, and CROs, providing eCOA and total consent solutions.

With its proven track record and dedication to innovation, Medable is poised to continue revolutionizing clinical trials and supporting the pharmaceutical industry. They are currently expanding their partnerships in Mexico, Argentina, and other challenging locations, further solidifying their position as a leader in the field.

Learn more by accessing the full article below.